Cara Therapeutics | CARA - DÍVIDA

Preço das Ações
3.39
Mudança Diária
0.17 5.28%
Mensal
-1.45%
Anual
-80.60%
Q2 Previsão
2.82




DÍVIDA Alterar Data
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Assertio Holdings USD 38.87M 615K 2023-09
Cara Therapeutics USD 0 0 2025-03
Cassava Sciences USD 0 0 2024-12
Chugai Pharma JPY 14.11B 1.93B 2022-12
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
J&J USD 47.93B 2.14B 2025-12
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Pacira USD 372.19M 4.53M 2025-12
Pfizer USD 60.85B 78M 2025-09
RedHill Biopharma USD 214K 142K 2025-06
Supernus Pharmaceuticals USD 42.21M 10.44M 2025-09
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12